Cervical squamous cell carcinoma
MONDO:0006143A squamous cell carcinoma arising from the cervical epithelium. It usually evolves from a precancerous cervical lesion. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors for cervical squamous cell carcinoma. The following histologic patterns have been described: conventional squamous cell carcinoma, papillary squamous cell carcinoma, transitional cell carcinoma, lymphoepithelioma-like carcinoma, verrucous carcinoma, condylomatous carcinoma and spindle cell carcinoma. Survival is most closely related to the stage of disease at the time of diagnosis.
Also known as: cervical squamous cell cancer, cervical squamous cell carcinoma, cervix squamous cell carcinoma, cervix uteri squamous cell carcinoma, squamous cell carcinoma of cervix, squamous cell carcinoma of cervix uteri, squamous cell carcinoma of the cervix, squamous cell carcinoma of the cervix uteri
2884 clinical trials for this condition and its sub-types, 36 tagged with Cervical squamous cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Cervical squamous cell carcinoma
-
Cervical adenosquamous carcinoma 16 trials
1 sub-type
-
Cervical basaloid carcinoma 0 trials
-
Cervical verrucous carcinoma 0 trials
-
Timing matters: early platelet booster may prevent dangerous drops in cervical cancer treatment
Disease control CompletedThis study looked at when to start giving a drug called rhTPO to cervical cancer patients whose platelet levels drop during chemoradiation. The goal was to see if starting treatment earlier could prevent severe low platelet counts. Researchers studied 75 patients and compared two…
Sponsor: Mei Feng • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Immunotherapy boosts standard treatment for aggressive cervical cancer
Disease control CompletedThis early-phase trial tested whether adding the immunotherapy drug atezolizumab before and during standard chemoradiation could help control advanced cervical cancer that has spread to lymph nodes. Forty participants received the combination to see if it activated the immune sys…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC